Koichi Motojima
About
In The Last Decade
Koichi Motojima
25 papers receiving 537 citations
Peers
Comparison fields: 5 of 55
- Oncology 386
- Surgery 233
- Cancer Research 124
- Epidemiology 110
- Molecular Biology 104
Countries citing papers authored by Koichi Motojima
This map shows the geographic impact of Koichi Motojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Motojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Motojima more than expected).
Fields of papers citing papers by Koichi Motojima
This network shows the impact of papers produced by Koichi Motojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Motojima. The network helps show where Koichi Motojima may publish in the future.
Co-authorship network of co-authors of Koichi Motojima
This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Motojima. A scholar is included among the top collaborators of Koichi Motojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Motojima. Koichi Motojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 5 | |
| 3 | 17 | |
| 4 | erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. | 28 |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 9 | |
| 8 | 93 | |
| 9 | 14 | |
| 10 | 22 | |
| 11 | [Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma]. | 5 |
| 12 | 3 | |
| 13 | 6 | |
| 14 | 1 | |
| 15 | 42 | |
| 16 | 0 | |
| 17 | 0 | |
| 18 | 92 | |
| 19 | 17 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.